Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination

GLIA

Volumn 60, Issue 7, 2012, Pages 1037-1052

  Xiao, Lin ^a   Guo, Dazhi ^a   Hu, Chun ^a   Shen, Weiran ^a   Shan, Lei ^b   Li, Cui ^a   Liu, Xiuyun ^a   Yang, Wenjing ^a   Zhang, Weidong ^b   He, Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cuprizone; Demyelination; Differentiation; Diosgenin; ERK; Estrogen receptor; OPC; Remyelination

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DIOSGENIN; FULVESTRANT; MIFEPRISTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REMYELINIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DIOSGENIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA; RATS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84860656906     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22333     Document Type: Article

References (63)

1. Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S, Beyer C. 2009. 17b-Estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57: 807-814.
2. Benghuzzi H, Tucci M, Eckie R, Hughes J. 2003. The effects of sustained delivery of diosgenin on the adrenal gland of female rats. Biomed Sci Instrum 39: 335-340.
3. Bruce CC, Zhao C, Franklin RJ. 2010. Remyelination-An effective means of neuroprotection. Horm Behav 57: 56-62.
4. Brück W, Kuhlmann T, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206: 181-185.
5. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. 1996. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17: 229-243.
6. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-173.
7. Chen PS, Shih YW, Huang HC, Cheng HW. 2011. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS ONE 6: e20164.
8. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A;WHI Investigators. 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial. JAMA 289: 3243-3253.
9. Confavreux C, Vukusic S, Adeleine P. 2003. Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process. Brain 126: 770-782.
10. Dawson MR, Polito A, Levine JM, Reynolds R. 2003. NG2-expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24: 476-488.
11. Dwosh E, Guimond C, Duquette P, Sadovnick AD. 2003. The interaction of MS, pregnancy: A critical review. Int MS J 10: 38-42.
12. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3: 705-714.
13. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9: 839-855.
14. Fyffe-Maricich SL, Karlo JC, Landreth GE, Miller RH. 2011. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci 31: 843-850.
15. Gensert JM, Goldman JE. 1997. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19: 197-203.
16. Goldman JE. 1992. Regulation of oligodendrocyte differentiation. Trends Neurosci 15: 359-362.
17. Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, Almazan G, Sánchez-Rodriguez MA, Molina-Holgado F, Molina-Holgado E. 2010. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation. Glia 58: 1913-1927.
18. Guo L, Eviatar-Ribak T, Miskimins R. 2010. Sp1 phosphorylation is involved in myelin basic protein gene transcription. J Neurosci Res 88: 3233-3242.
19. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH. 2000. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20: 2218-2228.
20. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. 1998. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58: 3833-3838.
21. Hu JG, Fu SL, Wang YX, Li Y, Jiang XY, Wang XF, Qiu MS, Lu PH, Xu XM. 2008. Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway. Neuroscience 151: 138-147.
22. Irvine KA, Blakemore WF. 2008. Remyelination protects axons from demyelination associated axon degeneration. Brain 131: 1464-1477.
23. Kieseier BC, Hemmer B, Hartung HP. 2005. Multiple sclerosis-Novel insights and new therapeutic strategies. Curr Opin Neurol 18: 211-220.
24. Kipp M, Beyer C. 2009. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front Neuroendocrinol 30: 188-200.
25. Kondo T, Raff MC. 2000. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289: 1754-1757.
26. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Brück W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131: 1749-1758.
27. Levine JM, Reynolds R, Fawcett JW. 2001. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24: 39-47.
28. Lucchinetti CF, Bruck W, Lassmann H. 2004. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 55: 458-468.
29. Marino M, Galluzzo P, Ascenzi P. 2006. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 7: 497-508.
30. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
31. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
32. Miller RH, Mi S. 2007. Dissecting demyelination. Nat Neurosci 10: 1351-1354.
33. Nishiyama A, Watanabe M, Yang Z, Bu J. 2002. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol 31: 437-455.
34. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129: 3165-3172.
35. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. New York: Academic Press.
36. Rajasekharan S, Baker KA, Horn KE, Jarjour AA, Antel JP, Kennedy TE. 2009. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 136: 415-426.
37. Raju J, Mehta R. 2009. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer 61: 27-35.
38. Raju J, Patlolla JM, Swamy MV, Rao CV. 2004. Diosgenin A steroid saponin of Trigonella foenum-graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 13: 1392-1398.
39. Ravikumar P, Anuradha CV. 1999. Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats. Phytother Res 13: 197-201.
40. Reichardt HM, Gold R, Lühder F. 2006. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Expert Rev Neurother 6: 1657-1670.
41. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J;WHI Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333.
42. Sauvaire Y, Ribes G, Baccou JC, Loubatieeres-Mariani MM. 1991. Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek. Lipids 26: 191-197.
43. Scott A, Higdon K, Tucci M, Benghuzzi H, Puckett A, Tsao A, Cason Z, Hughes J. 2001. The prevention of osteoporotic progression by means of steroid loaded TCPL drug delivery systems. Biomed Sci Instrum 37: 13-18.
44. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR. 2002. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52: 421-428.
45. Sidman RL, Abervine JB, Pierec ET. 1971. Atlas of the mouse brain and spinal cord. Cambridge, Massachusetts: Harvard University Press
46. Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR. 2003. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 171: 6267-6274.
47. Spassky N, Goujet-Zalc C, Parmantier E, Olivier C, Martinez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I, Zalc B, Thomas JL. 1998. Multiple restricted origin of oligodendrocytes. J Neurosci 15: 8331-8343.
48. Sperber BR, McMorris FA. 2001. Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes. J Neurosci Res 63: 303-312.
49. Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C. 2009. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int J Cancer 125: 961-967.
50. Su ZD, Yuan YM, Chen JJ, Zhu YL, Qiu Y, Zhu F, Huang AJ, He C. 2011. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-alpha. J Neurotrauma 28: 1089-1100.
51. Tada Y, Kanda N, Haratake A, Tobiishi M, Uchiwa H, Watanabe S. 2009. Novel effects of diosgenin on skin aging. Steroids 74: 504-511.
52. Taylor LC, Puranam K, Gilmore W, Ting JP, Matsushima KM. 2010. 17β-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Neurobiol Dis 39: 127-137.
53. Tyler WA, Gangoli N, Gokina P, Kim HA, Covey M, Levison SW, Wood L. 2009. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J Neurosci 29: 6367-6378.
54. Voskuhl RR. 2003. Hormone-based therapies in MS. Int MS J 10: 60-66.
55. Wang W, Gao XF, Xiao L, Xiang ZH, He C. 2011. KV7/KCNQ Channels are functionally expressed in oligodendrocyte progenitor cells. PLoS One 6: e21792.
56. Weiss LK, Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR.Norman SA, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Berlin JA, Weber AL, Doody DR, Wingo PA, McDonald JA, Malone KE, Folger SG, Spirtas R. 2002. Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol 100: 1148-1158.
57. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18: 601-609.
58. Xiao L, Feng, CZ, Chen YZ. 2010. Glucocorticoid rapidly enhances NMDA-evoked neurotoxicity by attenuating the NR2A-containing NMDA receptor-mediated ERK1/2 activation. Mol Endocrinol 24: 497-510.
59. Xiao L, Hu C, Feng CZ, Chen YZ. 2011. Switching of N-methyl-D-aspartate (NMDA) receptor-favorite intracellular signal pathways from ERK1/2 protein to p38 mitogen-activated protein kinase leads to developmental changes in NMDA neurotoxicity. J Biol Chem 286: 20175-20193.
60. Xiao L, Qi AQ, Chen YZ. 2005. Cultured embryonic hippocampal neurons deficient in glucocorticoid (GC) receptor: A novel model for studying nongenomic effects of GC in the neural system. Endocrinology 146: 4036-4041.
61. Xu JP, Zhao J, Li S. 2011. Roles of NG2 glial cells in diseases of the central nervous system. Neurosci Bull 27: 413-421.
62. Yen ML, Su JL, Chien CL, Tseng KW, Yang CY, Chen WF, Chang CC, Kuo ML. 2005. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol 68: 1061-1073.
63. Zhang Z, Cerghet M, Mullins C, Williamson M, Bessert D, Skoff R. 2004. Comparison of in vivo and in vitro subcellular localization of estrogen receptors alpha and beta in oligodendrocytes. J Neurochem 89: 674-684.